Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #9863 on Generex Biotechnology Corp. (fka GNBTQ)
namtae
10/15/19 9:37 AM
#9864 RE: docj #9863
NGIO is currently enrolling a Phase II trial to establish the recommended biologic dose